TMT-Based Multiplexed (Chemo)Proteomics on the Orbitrap Astral Mass Spectrometer
Molecular & Cellular Proteomics · 2025-05 · 24 (5) · 100968
DOI: 10.1016/j.mcpro.2025.100968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025-05. Verfasst von Yuchen He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States. Hauptthemen laut MEDLINE: Proteomics, Tandem Mass Spectrometry, Proteome, Mass Spectrometry. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Ongoing advancements in instrumentation has established mass spectrometry (MS) as an essential tool in proteomics research and drug discovery. The newly released Asymmetric Track Lossless (Astral) analyzer represents a major step forward in MS instrumentation. Here, we evaluate the Orbitrap Astral mass spectrometer in the context of tandem mass tag (TMT)-based multiplexed proteomics and activity-based proteome profiling, highlighting its sensitivity boost relative to the Orbitrap Tribrid platform-50% at the peptide and 20% at the protein level. We compare TMT data-dependent acquisition and label-free data-independent acquisition on the same instrument, both of which quantify over 10,000 human proteins per sample within 1 h. TMT offers higher quantitative precision and data completeness, while data-independent acquisition is free of ratio compression and is thereby more accurate. Our results suggest that ratio compression is prevalent with the high-resolution MS2-based quantification on the Astral, while real-time search-based MS3 quantification on the Orbitrap Tribrid platform effectively restores accuracy. Additionally, we benchmark TMT-based activity-based proteome profiling by interrogating cysteine ligandability. The Astral measures over 30,000 cysteines in a single-shot experiment, a 54% increase relative to the Orbitrap Eclipse. We further leverage this remarkable sensitivity to profile the target engagement landscape of FDA-approved covalent drugs, including sotorasib and adagrasib. We herein provide a reference for the optimal use of the advanced MS platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States.
- Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States.
- Thermo Fisher Scientific, Bremen, Germany.
- Thermo Fisher Scientific, San Jose, California, United States.
- Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States. Electronic address: joao_paulo@hms.harvard.edu.
- Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States. Electronic address: qing.yu@umassmed.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
He, Y., Yang, K., Li, S., Zeller, M., McAlister, G. C., Stewart, H. I., Hock, C., Damoc, E., Zabrouskov, V., Gygi, S. P., Paulo, J. A., & Yu, Q. (2025). TMT-Based Multiplexed (Chemo)Proteomics on the Orbitrap Astral Mass Spectrometer. Molecular & Cellular Proteomics, 24(5), 100968. https://doi.org/10.1016/j.mcpro.2025.100968
Vancouver
He Y, Yang K, Li S, Zeller M, McAlister GC, Stewart HI, et al. TMT-Based Multiplexed (Chemo)Proteomics on the Orbitrap Astral Mass Spectrometer. Molecular & Cellular Proteomics. 2025;24(5):100968. doi:10.1016/j.mcpro.2025.100968
BibTeX
@article{He2025,
author = {He, Yuchen and Yang, Ka and Li, Shaoxian and Zeller, Martin and McAlister, Graeme C and Stewart, Hamish I and Hock, Christian and Damoc, Eugen and Zabrouskov, Vlad and Gygi, Steven P and Paulo, Joao A and Yu, Qing},
title = {TMT-Based Multiplexed (Chemo)Proteomics on the Orbitrap Astral Mass Spectrometer},
journal = {Molecular & Cellular Proteomics},
year = {2025},
volume = {24},
number = {5},
pages = {100968},
doi = {10.1016/j.mcpro.2025.100968}
}
EUVIMED